<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-12.anc" start="4721" end="4727" sStart="4617" offset="104" sid="r11.strong.j.0949" wn="1" wnkey="strong%3:00:00::" annotator="vebatchelder" text="This activation of the p110-PI 3-kinase/PKB pathway, and inhibition of GSK3, delivers a strong anti-apoptotic signal to the cell [ 23, 24, 25]." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-2-12.anc" start="20191" end="20195" sStart="null" offset="0" sid="null" wn="1" wnkey="part%1:24:00::" annotator="veweser" text="GSK3?-dependent phosphorylation of p53 at serine 33 may be &lt;b&gt;part&lt;/b&gt; of other p53-regulatory pathways, such as oncogene activation or apoptosis, which are not directly activated by DNA-damage." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-2-12.anc" start="20191" end="20195" sStart="null" offset="0" sid="null" wn="" wnkey="null" annotator="tofox" text="GSK3?-dependent phosphorylation of p53 at serine 33 may be &lt;b&gt;part&lt;/b&gt; of other p53-regulatory pathways, such as oncogene activation or apoptosis, which are not directly activated by DNA-damage." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-12.anc" start="10783" end="10789" sStart="null" offset="73" sid="r9.level.n.0748" wn="2" wnkey="level%1:26:01::" annotator="brubin" text="Both the S33A and S37A mutations displayed slightly higher basal levels of transcriptional activity than the wtp53 protein." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-12.anc" start="4103" end="4111" sStart="null" offset="186" sid="r11.function.n.0223" wn="7" wnkey="function%1:10:00::" annotator="vebatchelder" text="In this study, we have examined how Glycogen Synthase Kinase 3? (GSK3?), a protein kinase involved in tumorigenesis, differentiation and apoptosis, regulates the function of p53 [ 23, 24]." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-12.anc" start="14982" end="14990" sStart="null" offset="95" sid="r11.function.n.0483" wn="2" wnkey="function%1:07:00::" annotator="adelpriore" text="However, disruption of GSK3? in mice results in embryonic lethality and impaired NF? B function [ 37], indicating that GSK3? cannot substitute for GSK3? in this model system." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-12.anc" start="11399" end="11406" sStart="null" offset="199" sid="r11.absence.n.0785" wn="1" wnkey="absence%1:26:00::" annotator="anfahmy" text="The ability of GSK3? to activate each construct was calculated by expressing the p53 transcriptional activity in the presence of GSK3? as a percentage of that observed in the absence of GSK3?." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-12.anc" start="8858" end="8865" sStart="null" offset="7" sid="r11.absence.n.0537" wn="1" wnkey="absence%1:26:00::" annotator="adelpriore" text="In the absence of p53, no phosphorylation by GSK3? was detected (fig 2)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-12.anc" start="15417" end="15421" sStart="null" offset="102" sid="r11.able.j.0146" wn="1" wnkey="able%3:00:00::" annotator="anfahmy" text="The GSK3? phosphorylation site was identified by mutagenesis as serine 33 of p53, and we were able to show that this was dependent on prior phosphorylation of serine 37 by DNA-PK." />
  </sentences>
</list>